IBS-80, LLC

IBS-80 - The breakthrough new approach to the evaluation and treatment of Irritable Bowel Syndrome.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Philadelphia, PA, USA
  • Currency USD
  • Founded January 2018
  • Employees 2
  • Incorporation Type LLC
  • Website ibs-80.com

Company Summary

Irritable Bowel Syndrome (IBS) affects 30 to 60 million Americans and, until now, has had no known cause and little effective treatment.

IBS-80 revolutionizes the treatment of IBS by using a routine dermatological procedure called patch testing to identify foods that cause a Type 4 allergic reaction - never associated with IBS before - on the skin. When IBS patients stop eating foods that cause a reaction, over 60% are helped, with 30% cured.

Team

  • David Blatte
    CEO

    Mr. Blatte is an attorney and the CEO and business manager of IBS-80, LLC. After graduating from the University of Pennsylvania Law School, he practiced in a number of legal specialties, including criminal law, legal malpractice, and the emergent field of animal law. Mr. Blatte founded and maintained a law practice and also has extensive experience with nonprofit organizations.

  • Michael Stierstorfer
    IBS-80 developer

    Dr. Stierstorfer, the developer of IBS-80, is a practicing dermatologist and Clinical Associate Professor of Dermatology at the University of Pennsylvania School of Medicine. He has been named a Philadelphia magazine Top DoctorsTM winner in Dermatology annually since 2018. He has been published in a number of peer-reviewed dermatology journals and participates in the Major League Baseball Skin Cancer Screening and Awareness Program.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free